UC seminar teaches lawyers, others acting techniques to enhance their skills
For all lawyers who take on “speaking parts” before the court, in negotiation, at deposition or trial, or for those who must speak with clients, committees or boards, the Center for Practice at the College of Law is offering the seminar “Stage Directions for Lawyers’ Speaking Parts." The event will be held 1-4:30 p.m., March 29, in room 114 at the College of Law.
The seminar will be led by faculty member Katherine Webster, CCM and London’s Royal Central School of Speech and Drama. Webster will introduce techniques for vocal reach and demonstrate how the attendees can strengthen their impact through timing, punctuation and pitch. The interactive program will give participants opportunity to practice the techniques. In addition, she will focus on the importance of body positioning, movement and gesture during delivery and their impact on judges, juries or larger audiences.
CLE: 3.25 hours (application pending). Cost: $25 (early registration); $35 after. Proceeds will help fund Cincinnati Law’s students’ coaching in trial practice class and in preparation for polished performance in trial practice competitions.
Tags
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
The legacy of Cincinnati bootlegger George Remus
December 11, 2025
WLWT Journalist Lindsay Stone spoke with Christopher Bryant, a professor in University of Cincinnati College of Law, about the legal troubles of Cincinnati bootlegger George Remus.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.